Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Leukemia, Myeloid, Chronic-Phase
×
asciminib
×
Clear all
Filters
3
NCT04666259
2025-10-16
AIM4CML
Novartis
Phase 3
Completed
56 enrolled
18 charts